ALDR - Alder BioPharmaceuticals Inc. (ALDR) CEO Bob Azelby on Q2 2019 Results - Earnings Call Transcript
Alder BioPharmaceuticals, Inc. (ALDR)
Q2 2019 Results Conference Call
August 6, 2019 05:00 PM ET
Company Participants
Michael Horowicz - Stern Investor Relations
Bob Azelby - Chief Executive Officer
Paul Streck - Chief Medical Officer
Nadia Dac - Chief Commercial Officer
Carlos Campoy - Chief Financial Officer
Erin Lavelle - Chief Operating Officer
Conference Call Participants
Brian Abrahams - RBC Capital Markets
Yuko Oku - JPMorgan
Charles Duncan - Cantor Fitzgerald
Jim Birchenough - Wells Fargo
Evan Seigerman - Credit Suisse
Rudy Li - SVB Leerink
Alexander Lim - Mizuho
Na Sun - BMO Capital